Cargando…
Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
PURPOSE: Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126000/ https://www.ncbi.nlm.nih.gov/pubmed/27920514 http://dx.doi.org/10.2147/COPD.S114497 |
_version_ | 1782470040377884672 |
---|---|
author | Oki, Yutaro Kaneko, Masahiro Fujimoto, Yukari Sakai, Hideki Misu, Shogo Mitani, Yuji Yamaguchi, Takumi Yasuda, Hisafumi Ishikawa, Akira |
author_facet | Oki, Yutaro Kaneko, Masahiro Fujimoto, Yukari Sakai, Hideki Misu, Shogo Mitani, Yuji Yamaguchi, Takumi Yasuda, Hisafumi Ishikawa, Akira |
author_sort | Oki, Yutaro |
collection | PubMed |
description | PURPOSE: Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in patients with COPD have not been reported. We hypothesized that the PA:A ratio correlated with EID and that results of the 6-minute walk test (6MWT) would be useful for predicting the risk associated with PA:A >1. PATIENTS AND METHODS: We retrospectively measured lung function, 6MWT, emphysema area, and PA enlargement on CT in 64 patients with COPD. The patients were classified into groups with PA:A ≤1 and >1. Receiver-operating characteristic curves were used to determine the threshold values with the best cutoff points to predict patients with PA:A >1. RESULTS: The PA:A >1 group had lower forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), FEV(1):FVC ratio, diffusion capacity of lung carbon monoxide, 6MW distance, and baseline peripheral oxygen saturation (SpO(2)), lowest SpO(2), highest modified Borg scale results, percentage low-attenuation area, and history of acute COPD exacerbations ≤1 year, and worse BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise) index results (P<0.05). Predicted PA:A >1 was determined for SpO(2) during 6MWT (best cutoff point 89%, area under the curve 0.94, 95% confidence interval 0.88–1). SpO(2) <90% during 6MWT showed a sensitivity of 93.1, specificity of 94.3, positive predictive value of 93.1, negative predictive value of 94.3, positive likelihood ratio of 16.2, and negative likelihood ratio of 0.07. CONCLUSION: Lowest SpO(2) during 6MWT may predict CT-measured PA:A, and lowest SpO(2) <89% during 6MWT is excellent for detecting pulmonary hypertension in COPD. |
format | Online Article Text |
id | pubmed-5126000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-51260002016-12-05 Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD Oki, Yutaro Kaneko, Masahiro Fujimoto, Yukari Sakai, Hideki Misu, Shogo Mitani, Yuji Yamaguchi, Takumi Yasuda, Hisafumi Ishikawa, Akira Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in patients with COPD have not been reported. We hypothesized that the PA:A ratio correlated with EID and that results of the 6-minute walk test (6MWT) would be useful for predicting the risk associated with PA:A >1. PATIENTS AND METHODS: We retrospectively measured lung function, 6MWT, emphysema area, and PA enlargement on CT in 64 patients with COPD. The patients were classified into groups with PA:A ≤1 and >1. Receiver-operating characteristic curves were used to determine the threshold values with the best cutoff points to predict patients with PA:A >1. RESULTS: The PA:A >1 group had lower forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), FEV(1):FVC ratio, diffusion capacity of lung carbon monoxide, 6MW distance, and baseline peripheral oxygen saturation (SpO(2)), lowest SpO(2), highest modified Borg scale results, percentage low-attenuation area, and history of acute COPD exacerbations ≤1 year, and worse BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise) index results (P<0.05). Predicted PA:A >1 was determined for SpO(2) during 6MWT (best cutoff point 89%, area under the curve 0.94, 95% confidence interval 0.88–1). SpO(2) <90% during 6MWT showed a sensitivity of 93.1, specificity of 94.3, positive predictive value of 93.1, negative predictive value of 94.3, positive likelihood ratio of 16.2, and negative likelihood ratio of 0.07. CONCLUSION: Lowest SpO(2) during 6MWT may predict CT-measured PA:A, and lowest SpO(2) <89% during 6MWT is excellent for detecting pulmonary hypertension in COPD. Dove Medical Press 2016-11-22 /pmc/articles/PMC5126000/ /pubmed/27920514 http://dx.doi.org/10.2147/COPD.S114497 Text en © 2016 Oki et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Oki, Yutaro Kaneko, Masahiro Fujimoto, Yukari Sakai, Hideki Misu, Shogo Mitani, Yuji Yamaguchi, Takumi Yasuda, Hisafumi Ishikawa, Akira Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD |
title | Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD |
title_full | Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD |
title_fullStr | Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD |
title_full_unstemmed | Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD |
title_short | Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD |
title_sort | usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in copd |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126000/ https://www.ncbi.nlm.nih.gov/pubmed/27920514 http://dx.doi.org/10.2147/COPD.S114497 |
work_keys_str_mv | AT okiyutaro usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT kanekomasahiro usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT fujimotoyukari usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT sakaihideki usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT misushogo usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT mitaniyuji usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT yamaguchitakumi usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT yasudahisafumi usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd AT ishikawaakira usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd |